The phytohormone property of equol has proved to be beneficial in many in vitro breast cancer studies as it is reported to bind to both estrogen receptors i.e., ERα and ERß, and is implicated in the inhibition of proliferation and induction of apoptosis in breast cancer cells. Here, ESR1 is linked to breast carcinoma.